ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-use products in Speke, Liverpool, to address an increased ...
Bormioli Pharma, an international leader in pharmaceutical packaging and medical devices, announced the third edition of its Sustainability Report. This edition outlines and consolidates the stro...
Fragmentation in healthcare data is a stark reality today. Many patients’ medical records lie dispersed among several filing cabinets, each originating from a separate physician’s office, hos...
The European Parliament recently introduced compromise amendments to the revised EU pharmaceutical legislation introduced in April 2023, and they attempt to address some of the concerns of the ph...
With a growing shift towards tailored therapies for cancer treatment, personalized medicine emerges as a groundbreaking solution. Cancer has been a major cause of concern among healthcare profess...
As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical medicines and go on to formally launch the Critical Medicines Alliance...
https://www.worldpharmatoday.com/news/ema-offers-plans-to-enhance-availability-of-vital-medicines/
In an interview with Mats Holmberg, a fertility expert, the significance of male infertility in today’s context is highlighted. Male infertility contributes significantly to overall infertility...
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced late-stage customization capabilities for its RFID-Labels...
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch H...
The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products by the FDA’s Center for Biologics Research and Evaluati...
https://www.worldpharmatoday.com/news/cell-gene-therapies-fda-regulatory-considerations-in-2024/